Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsNipun mehta

    Nipun Mehta

    Jump to

    • Crack The Code: Aims to educate investors

      Crack The Code is a brand new series which aims to educate investors about making informed decisions.

    • Mkt consolidating, may see 3-5% upside/downside: Nipun Mehta

      Nipun Mehta, Founder & CEO, Blue Ocean Capital Advisors is of the view that market is currently consolidatng and it is possible for the Indian benchmark indices to see a 3-5 percent upmove or down move.

    • Upward momentum for mkt to continue; like autos, IT: Nipun Mehta

      Nipun Mehta, Founder & CEO, Blue Ocean Capital Advisors is of the belief that upward momentum for the market will continue, backed by strong foreign institutional investor (FII) buying.

    • Mkt consolidation a positive but headwinds continue: Blue Ocean

      The ongoing consolidation in the stock markets is a positive but till there is global stability, both in terms of macro events as well as flows, some volatility can be expected, says Nipun Mehta of Blue Ocean Capital.

    • What next if Fed hikes rates tomorrow?

      Nipun Mehta, Founder and CEO of Blue Ocean Capital Advisors says the Fed may hike rates from 15 basis points to 25 basis points as far as domestic markets are concerned.

    • Use mkt fall to buy stks; like banking, IT, pharma: Experts

      Nipun Mehta says the banking, IT and pharma sector are likely to do well.

    • Returns could take longer but buy on dips, says Nipun Mehta

      For investing, one should look at getting into fundamentally sound stocks and sectors that have consistently performed but the wait could be longer, says Nipun Mehta of Blue Ocean Capital Advisors.

    • Nifty to rally further; hold on to IT, pharma: Experts

      According to Sukhani, IT and pharma are still worth buying as these two sectors have been consistently performing well. He believes Nifty will rally in the coming days and therefore, these sectors are likely to outperform.

    • Nippon Life hiking stake in Rel Cap: Should we invest now?

      P Phani Sekhar of Angel Broking and Nipun Mehta of Blue Ocean Capital Advisors believe it is the right time to buy the stock.

    • Avoid betting on Bank Nifty now; go for defensives: Sukhani

      In an interview to CNBC-TV18 market experts Sudarshan Sukhani of s2analytics.com, P Phani Sekhar of Angel Broking and Nipun Mehta of Blue Ocean Capital Advisors share their views on the market and specific stocks going ahead

    • Will you buy Ranbaxy amid uncertainty over 2 key generics?

      According to Mehta, of late Ranbaxy has been in the news for all the wrong reasons barring its merger with pharma behemoth Sun Pharma, making it a potential trigger for investors to buy the stock.

    • Is Sun Pharma expensive at current valuations?

      Purely from a short-term point of view there might not be too much of significant run up but purely on a fundamental basis Sun Pharma looks fairly strong, does warrant a presence in portfolios, has a fair amount of institutional investment as well, says Nipun Mehta.

    • Nifty to see big bouts of resistance soon: Experts

      Rahul Mohindar of viratechindia.com advises investors to shy away from technology stocks and those from oil and gas space.

    • Sun Pharma a must in core portfolio: Experts

      Market experts Nipun Mehta and Dilip Bhatdo see no negatives for Sun Pharma if the Ranbaxy deal goes through.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347